ICL Common Stock Total Equity from 2010 to 2024

ICL Stock  USD 4.62  0.18  4.05%   
ICL Israel Common Stock Total Equity yearly trend continues to be quite stable with very little volatility. The value of Common Stock Total Equity is projected to decrease to about 592.8 M. Common Stock Total Equity is the total value of common stock equity held by shareholders, representing their ownership interest in the company. View All Fundamentals
 
Common Stock Total Equity  
First Reported
2001-12-31
Previous Quarter
546 M
Current Value
547 M
Quarterly Volatility
6.9 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check ICL Israel financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ICL Israel's main balance sheet or income statement drivers, such as Depreciation And Amortization of 273.3 M, Interest Expense of 119.6 M or Selling General Administrative of 370.7 M, as well as many indicators such as Price To Sales Ratio of 0.81, Dividend Yield of 0.0407 or PTB Ratio of 1.06. ICL financial statements analysis is a perfect complement when working with ICL Israel Valuation or Volatility modules.
  
Check out the analysis of ICL Israel Correlation against competitors.

Latest ICL Israel's Common Stock Total Equity Growth Pattern

Below is the plot of the Common Stock Total Equity of ICL Israel Chemicals over the last few years. It is the total value of common stock equity held by shareholders, representing their ownership interest in the company. ICL Israel's Common Stock Total Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ICL Israel's overall financial position and show how it may be relating to other accounts over time.
Common Stock Total Equity10 Years Trend
Slightly volatile
   Common Stock Total Equity   
       Timeline  

ICL Common Stock Total Equity Regression Statistics

Arithmetic Mean551,753,892
Geometric Mean551,238,488
Coefficient Of Variation4.61
Mean Deviation15,625,813
Median545,000,000
Standard Deviation25,434,383
Sample Variance646.9T
Range106.5M
R-Value0.66
Mean Square Error390.4T
R-Squared0.44
Significance0.01
Slope3,771,031
Total Sum of Squares9056.7T

ICL Common Stock Total Equity History

2024592.8 M
2023627.9 M
2018546 M
2017545 M
2015544 M
2014543.1 M
2013542.9 M

About ICL Israel Financial Statements

ICL Israel investors utilize fundamental indicators, such as Common Stock Total Equity, to predict how ICL Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Common Stock Total Equity627.9 M592.8 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether ICL Israel Chemicals is a strong investment it is important to analyze ICL Israel's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ICL Israel's future performance. For an informed investment choice regarding ICL Stock, refer to the following important reports:
Check out the analysis of ICL Israel Correlation against competitors.
You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Fertilizers & Agricultural Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ICL Israel. If investors know ICL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ICL Israel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.18)
Dividend Share
0.2
Earnings Share
0.31
Revenue Per Share
5.373
Quarterly Revenue Growth
(0.06)
The market value of ICL Israel Chemicals is measured differently than its book value, which is the value of ICL that is recorded on the company's balance sheet. Investors also form their own opinion of ICL Israel's value that differs from its market value or its book value, called intrinsic value, which is ICL Israel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ICL Israel's market value can be influenced by many factors that don't directly affect ICL Israel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ICL Israel's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICL Israel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICL Israel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.